Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid

Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid

US Patent 9867868 · Granted Jan 16, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Electronic device having multilayered substrate and manufacturing method thereof2025
Circuit board and semiconductor module2024
Stabilized external preparation comprising thymosin beta 4 as an active ingredie2021
Methods of treating dry eye syndrome2021
Methods of treating dry eye syndrome2021
Method for preparing ophthalmic preparation containing thymosin beta-42020
Method for preparing ophthalmic preparation containing thymosin beta-42020
Organic compound, near-infrared fluorescent constant medium containing same, and2019
Composition containing thymosin beta 4, and pharmaceutical formulation comprisin2019
Composition containing thymosin beta 4, and pharmaceutical formulation comprisin2019
Composition containing thymosin beta 4, and pharmaceutical formulation comprisin2019
Memory module and memory system2017